Company adds U.K. and Ireland to existing U.S. and Canadian license to CellCelector.
The Automation Partnership negotiated distribution rights to Aviso’s CellCelector™ automated stem cell picker in the U.K. and Ireland. TAP will also continue to service the product in North America, under the terms of its previous distribution agreement, signed in January 2009, granting the firm marketing rights to CellCelector in the U.S. and Canada.
Aviso claims the patented CellCelector allows the automated selection and harvesting of a variety of stem cell types. The firm describes the system as a freely configurable tool for the automated transfer of single cells and cell colonies.
Aviso says that the CellCelector system is already used for a range of applications, ranging from the isolation and transfer of single cells and cell colonies from liquid, semisolid, or solid medium through to the isolation of cell material prepared from histological tissue sections.
